2020
| Encephalopathy associated with COVID-19 in a patient with multiple sclerosis |
| Neural implant for the treatment of multiple sclerosis |
| Burden of musculoskeletal disorders in Iran during 1990–2017: estimates from the Global Burden of Disease Study 2017 |
| Evaluation of the rate of COVID-19 infection, hospitalization and death among Iranian patients with multiple sclerosis |
| Stressful life events, socioeconomic status, and the risk of neuromyelitis optica spectrum disorder: A population-based case-control study |
| Preliminary study of analgesic effect of bumetanide on neuropathic pain in patients with spinal cord injury |
| Decreased serum levels of interleukin-17, interleukin-23, TGF-β in pemphigus vulgaris patients, and their association with disease phase |
| Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 |
| Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 |
| Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 |
| Five insights from the Global Burden of Disease Study 2019 |
| Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019 |
| The role of the brain in the treatment of multiple sclerosis as a connectomopathy |
| Anti-N-methyl-D-aspartate receptor optic neuritis in a patient without history of encephalopathy |
| Risk of cancer in multiple sclerosis (MS): A systematic review and meta-analysis |
| Evaluation of emotional intelligence (EI) in neuromyelitis optica spectrum disorder (NMOSD) patients compared to healthy individuals |
| Increased level of caspase-1 in the serum of relapsing-remitting multiple sclerosis (RRMS) Patients |
| Evaluation of COVID-19 infection in patients with Neuromyelitis optica spectrum disorder (NMOSD): A report from Iran |
| Epidemiology of neuromyelitis optica spectrum disorder in Tehran, Iran: the prevalence, baseline characteristics, and clinical aspects |
| Novel FMRI-Compatible wrist robotic device for brain activation assessment during rehabilitation exercise |
| The prevalence of migraine in multiple sclerosis (MS): A systematic review and meta-analysis |
| A case of possible atypical demyelinating event of the central nervous system following COVID-19 |
| Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection |
| Adipose-Derived Mesenchymal Stem Cells and Conditioned Medium Attenuate the Memory Retrieval Impairment During Sepsis in Rats |
| Differential expressions of SIRT1, SIRT3, and SIRT4 in peripheral blood mononuclear cells from patients with type 2 diabetic retinopathy |
| Efficacy and safety of rituximab in treating patients with multiple sclerosis (MS): A systematic review and meta-analysis |
| Epidemiology of familial multiple sclerosis: A population-based study in Tehran during 1999–2018 |
| B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran |
| Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000-17 |
| Author Correction: Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017 (Nature Medicine, (2020), 26, 5, (750-759), 10.1038/s41591-020-0807-6) |
| The big challenge for neurologists in treating patients with multiple sclerosis in the post-COVID-19 era |
| Rehabilitation recommendations for multiple sclerosis patients during the covid-19 pandemic |
| Effect of pregnancy and exclusive breastfeeding on multiple sclerosis relapse rate and degree of disability within two years after delivery |
| Evaluation of types of psychological disorders in patients with neuromyelitis optica spectrum disorder (NMOSD) |
| Knowledge regarding COVID-19 pandemic in patients with multiple sclerosis (MS): A report from Iran |
| The possible beneficial effects of higher vitamin B6 intake from diet on cognitive function of patients with neuromyelitis optica spectrum disorder |
| Sensory-neural hearing loss as an early rebound relapse after fingolimod cessation in multiple sclerosis |
| Molecular detection of epstein–barr virus, human herpes virus 6, cytomegalovirus, and hepatitis B virus in patients with multiple sclerosis |
| Prevalence of anti-jc virus antibody seropositivity in patients with multiple sclerosis: A systematic review and meta-Analysis |
| Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000-17: Analysis for the Global Burden of Disease Study 2017 |
| Department of Error: Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000–17: analysis for the Global Burden of Disease Study 2017 (The Lancet (2020) 395(10239) (1779–1801), (S0140673620301148), (10.1016/S0140-6736(20)30114-8)) |
| One Aspect of Coronavirus disease (COVID-19) Outbreak in Iran: High Anxiety among MS Patients |
| Psychiatric advice during Covid-19 pandemic for patients with multiple sclerosis |
| Neuropsychiatric and cognitive effects of the COVID-19 outbreak on multiple sclerosis patients |
| The Association between Vitamin D Deficiency and variants of Vitamin D Binding protein gene among Healthy Iranian Adults |
| A Randomized, Triple-blind Placebo-controlled Trial to Determine the Effect of Saffron on the Serum Levels of MMP-9 and TIMP-1 in Patients with Multiple Sclerosis |
| Application of Probiotics in Folate Bio-Fortification of Yoghurt |
| Immune Reconstitution Therapy or Continuous Immunosuppression for the Management of Active Relapsing–Remitting Multiple Sclerosis Patients? A Narrative Review |
| Evidence of an increased prevalence of multiple sclerosis: A population-based study of Tehran registry during 1999-2018 |
| Tumefactive demyelinating lesions after initiating fingolimod in patient with multiple sclerosis: A case report |
| Staphylococcal enterotoxin B increased severity of experimental model of multiple sclerosis |
| Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017 |
| Evaluation of the opinion of patients with multiple sclerosis on the outcomes of catching COVID-19 and its effects on the MS symptoms |
| Opportunities and threats: The necessity of research in dealing with the rapid spread of coronavirus disease 2019 (COVID-19) in Iran |
| Neuro-Behcet’s disease: An update on diagnosis, differential diagnoses, and treatment |
| History of multiple sclerosis in Iran |
| Efficacy and safety of rituximab in patients with refractory neuromyelitis optica spectrum disorders: A prospective observation in Iranian cases |
| Mesenchymal stem cell-derived exosomes: A promising therapeutic ace card to address autoimmune diseases |
| The Putative Association of TOB1-AS1 Long Non-coding RNA with Immune Tolerance: A Study on Multiple Sclerosis Patients |
| Whey protein plus lipoic acid supplementation improves inflammatory and antioxidant markers of patients with acute ischemic stroke: A double-blind, randomized controlled clinical trial |
| Dietary patterns interact with chromosome 9p21 rs1333048 polymorphism on the risk of obesity and cardiovascular risk factors in apparently healthy Tehrani adults |
| Environmental and genetic risk factors in the development of neuromyelitis optica |
| Bladder dysfunction in iranian patients with multiple sclerosis |
| Multiple sclerosis and human leukocyte antigen genotypes: Focus on the Middle East and North Africa region |
| The co-occurrence of multiple sclerosis and Evans syndrome: A case report |
| Progressive myelopathy in a patient with pediatric onset neuromyelitis optica spectrum disorder: A case report and a mini review |
| Evaluation of the level of anxiety among iranian multiple sclerosis fellowships during the outbreak of COVID-19 |
| Aggressive course of cognitive impairment in multiple sclerosis: A new term for the management of patients |
| Ischemic Stroke in Patients with COVID-19 Disease: A Report of 10 Cases from Iran |
| Persian adaptation of actionable bladder symptom screening tool among patients with multiple sclerosis |
| Tumefactive demyelinating lesions in a patient with multiple sclerosis developed two days after the injection of rituximab |
| Low carbohydrate diet score and odds of neuromyelitis optica spectrum disorder: A case-control study |
| The Influence of Reactive Oxygen Species in the Immune System and Pathogenesis of Multiple Sclerosis |
| Umbilical cord mesenchymal stem cells as well as their released exosomes suppress proliferation of activated PBMCs in multiple sclerosis |
| Effect of Whey Protein Supplementation on Inflammatory and Antioxidant Markers, and Clinical Prognosis in Acute Ischemic Stroke (TNS Trial): A Randomized, Double Blind, Controlled, Clinical Trial |
| Effects of alpha lipoic acid supplementation on serum levels of oxidative stress, inflammatory markers and clinical prognosis among acute ischemic stroke patients: A randomized, double blind, TNS trial |
| Investigating the association of polymorphisms of ANKRD55 and MMEL1 with susceptibility to multiple sclerosis in Iranian population |
| Redox Imbalance in CD4+ T Cells of Relapsing-Remitting Multiple Sclerosis Patients |
| Association of HLA-DRA and IL2RA Polymorphisms with the Severity and Relapses Rate of Multiple Sclerosis in an Iranian Population |
| Analysis of Single Nucleotide Polymorphisms in HLA-DRA, IL2RA, and HMGB1 Genes in Multiple Sclerosis |
| Dietary total antioxidant capacity and colorectal cancer and colorectal adenomatous polyps: A case-control study |
| Diet-dependent acid load and the risk of colorectal cancer and adenoma: A case-control study |
| Salivary profile and dental status of patients with multiple sclerosis [Profil ślinowy i stan uzębienia pacjentów ze stwardnieniem rozsianym] |
| Incidence of seroconversion and sero-reversion in patients with multiple sclerosis (MS) who had been treated with natalizumab: A systematic review and meta-analysis |
| Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines |
| Estimating global injuries morbidity and mortality: Methods and data used in the Global Burden of Disease 2017 study |
| Global injury morbidity and mortality from 1990 to 2017: Results from the global burden of disease study 2017 |
2019
2018
Lifestyle factors and multiple sclerosis: A population-based incident case-control study.
Environmental risk factors in neuromyelitis optica spectrum disorder: a case-control study.
Demyelination with preferential MAG loss: A complex message from MS paraffin blocks.
HOTAIR but not ANRIL long non-coding RNA contributes to the pathogenesis of multiple sclerosis.
Progressive solitary sclerosis presented with diplopia: A case report.
Human herpesvirus 8 DNA detection and variant analysis in patients with multiple sclerosis.
Perceived Social Stigma in Patients with Multiple Sclerosis: A Study from Iran.
Incidental findings on cervical spine computed tomography scans: overlooked and unimportant?
Early-Onset Multiple Sclerosis: Reports of 300 Patients from Iran.
The prevalence, incidence and familial recurrence of multiple sclerosis in Tehran, Iran.
2017
Reply to Urbanization Theory for Growing Trend of Multiple Sclerosis Letter.
Neuromyelitis optica spectrum disorders in Iran.
2015
2014
Islamic fasting and multiple sclerosis
2013
Evaluation of cytokines in multiple sclerosis patients treated with mesenchymal stem cells
Inhibitor IκBα promoter functional polymorphisms in patients with multiple sclerosis
Impact of vitamin A supplementation on RAR gene expression in multiple sclerosis patients
Determinants of sexual dysfunction in women with multiple sclerosis
Sexual function in women with multiple sclerosis